Prostate Cancer Repository Network (PCBN)- Washington University Network Site
Abstract
Washington University School of Medicine and the Alvin J. Siteman Cancer Center have a long standing tradition of supporting multi-institutional cancer trials, scientific collaborations, and coordinated biorepository operations with all of the expertise, resources, operational management and personnel required to be a successful Prostate Cancer Biorepository Network (PCBN) resource site. Our proposed PCBN site aims to contribute biospecimens from prostate cancer patients with high risk disease. Within these populations, the study team will target African-American prostate cancer patients. Increasing the number of African-American men present in our biorepository will strengthen the generalizability of results obtained from the use of biospecimens from our PCBN site. The added benefits of our long-term follow-up, comprehensive medical, and survey data on diet and social factors of the participant will allow researchers to explore the effects of genes and the environment on prostate cancer recurrence and mortality. The participants in our PCBN site may not directly benefit from participation in the biorepository; however, what we learn from analyses of their samples will greatly benefit the next generation by providing answers to why some men are diagnosed with more aggressive prostate cancer than other men and what clinicians and patients can do to reduce their risk of prostate cancer recurrence and mortality.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2020
- Accession Number
- AD1118629
Entities
People
- Bettina F. Drake
Organizations
- Washington University in St. Louis